Skip to Content

145 145 (Rivastigmine 1.5 mg)

This pill with imprint "145 145" is Yellow, Capsule-shape and has been identified as Rivastigmine tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Rivastigmine is used in the treatment of lewy body dementia; parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rivastigmine tartrate

Imprint:
145 145
Strength:
1.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
gelatin
titanium dioxide
D&C Red No. 28
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
68084-0550 Amerisource Health Services

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide